{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T12:55:32Z","timestamp":1789736132133,"version":"4.0.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institute of Health grants","award":["R01 MH104603"],"award-info":[{"award-number":["R01 MH104603"]}]},{"name":"National Institute of Health grants","award":["P30 HD002528"],"award-info":[{"award-number":["P30 HD002528"]}]},{"name":"National Institute of Health grants","award":["R01 DA039687"],"award-info":[{"award-number":["R01 DA039687"]}]},{"name":"University of Kansas Strategic Initiatives"},{"name":"NIH grants","award":["P20 GM103638"],"award-info":[{"award-number":["P20 GM103638"]}]},{"name":"NIH grants","award":["UL1 TR000001"],"award-info":[{"award-number":["UL1 TR000001"]}]},{"name":"NIH grants","award":["UL1RR033179"],"award-info":[{"award-number":["UL1RR033179"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.neuropharm.2016.11.014","type":"journal-article","created":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T15:13:44Z","timestamp":1479914024000},"page":"77-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Pramipexole enhances disadvantageous decision-making: Lack of relation to changes in phasic dopamine release"],"prefix":"10.1016","volume":"114","author":[{"given":"Romina","family":"Pes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean C.","family":"Godar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew T.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren M.","family":"Burgeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hunter J.","family":"Strathman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Jarmolowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Devoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Levant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4498-9637","authenticated-orcid":false,"given":"Marco","family":"Bortolato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2016.11.014_bib1","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1093\/brain\/awp170","article-title":"At-risk for pathological gambling: imaging neural reward processing under chronic dopamine agonists","volume":"132","author":"Abler","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2016.11.014_bib2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.baga.2015.06.001","article-title":"The vulnerable ventral tegmental area in Parkinson's disease","volume":"5","author":"Alberico","year":"2015","journal-title":"Basal Ganglia"},{"key":"10.1016\/j.neuropharm.2016.11.014_bib3","series-title":"Basic Electrophysiological Methods","article-title":"Fast scan cyclic voltammetry in behaving animals","author":"Arnold","year":"2015"},{"key":"10.1016\/j.neuropharm.2016.11.014_bib4","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1523\/JNEUROSCI.2225-15.2016","article-title":"Dopamine D3 receptors modulate the ability of Win-paired cues to increase risky choice in a rat gambling task","volume":"36","author":"Barrus","year":"2016","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.11.014_bib5","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00213-006-0578-x","article-title":"The debate over dopamine's role in reward: the case for incentive salience","volume":"191","author":"Berridge","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2016.11.014_bib6","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1093\/brain\/awp094","article-title":"Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinson's patients","volume":"132","author":"Bodi","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2016.11.014_bib7","doi-asserted-by":"crossref","first-page":"8574","DOI":"10.1523\/JNEUROSCI.0225-12.2012","article-title":"NMDARs mediate the role of monoamine oxidase A in pathological aggression","volume":"32","author":"Bortolato","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.11.014_bib8","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nmeth.1412","article-title":"Chronic microsensors for longitudinal, subsections dopamine detection in behaving animals","volume":"7","author":"Clark","year":"2010","journal-title":"Nat. Methods"},{"key":"10.1016\/j.neuropharm.2016.11.014_bib9","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.neuropsychologia.2006.03.030","article-title":"Reversal learning in Parkinson's disease depends on medication status and outcome valence","volume":"44","author":"Cools","year":"2006","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.neuropharm.2016.11.014_bib10","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1002\/mds.23247","article-title":"Risk and learning in impulsive and nonimpulsive patients with Parkinson's disease","volume":"25","author":"Djamishidian","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuropharm.2016.11.014_bib11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00213-003-1528-5","article-title":"Behavioral sensitization to amphetamine in rats: changes in the rhythm of head movements during focused stereotypies","volume":"170","author":"Fowler","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2016.11.014_bib12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0165-0270(01)00359-4","article-title":"A\u00a0force-plate actometer for quantitating rodent behaviors: illustrative data on locomotion, rotation, spatial patterning, stereotypies, and tremor","volume":"107","author":"Fowler","year":"2001","journal-title":"J.\u00a0Neurosci. Meth"},{"key":"10.1016\/j.neuropharm.2016.11.014_bib13","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.bbr.2009.03.022","article-title":"Force-plate quantification of progressive behavioral deficits in the R6\/2 mouse model of Huntington's disease","volume":"202","author":"Fowler","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2016.11.014_bib14","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1111\/bph.13243","article-title":"The D1CT-7 mouse model of Tourette syndrome displays sensorimotor gating deficits in response to spatial confinement","volume":"173","author":"Godar","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.11.014_bib15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/jcp.0b013e3181602fab","article-title":"Effects of low to moderate acute doses of pramipexole on impulsivity and cognition in healthy volunteers","volume":"28","author":"Hamidovic","year":"2008","journal-title":"J.\u00a0Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2016.11.014_bib16","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0376-6357(03)00141-4","article-title":"Is discounting impulsive?. Evidence from temporal and probability discounting in gambling and non-gambling college students","volume":"64","author":"Holt","year":"2003","journal-title":"Behav. Process."},{"key":"10.1016\/j.neuropharm.2016.11.014_bib17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00213-010-2006-5","article-title":"Effects of acute pramipexole on preference for gambling-like schedules of reinforcement in rats","volume":"213","author":"Johnson","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2016.11.014_bib18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1037\/a0027117","article-title":"Effects of acute pramipexole on male rats' preference for gambling-like rewards II","volume":"20","author":"Johnson","year":"2012","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2016.11.014_bib19","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/jeab.21","article-title":"Pramipexole-induced disruption of behavioral processes fundamental to intertemporal choice","volume":"99","author":"Johnson","year":"2013","journal-title":"J.\u00a0Exp. Anal. Behav."},{"key":"10.1016\/j.neuropharm.2016.11.014_bib20","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/mds.23701","article-title":"Reward processing abnormalities in Parkinson's disease","volume":"26","author":"Kapogiannis","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuropharm.2016.11.014_bib21","first-page":"603","article-title":"Dopamine agonists and pathologic behaviors","volume":"2012","author":"Kelley","year":"2012","journal-title":"Parkinson Dis."},{"key":"10.1016\/j.neuropharm.2016.11.014_bib22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s002130050174","article-title":"Symmetrical effects of amphetamine and alpha-flupenthixol on conditioned punishment and conditioned reinforcement: contrasts with midazolam","volume":"129","author":"Killcross","year":"1997","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2016.11.014_bib23","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1212\/WNL.49.1.162","article-title":"Clinical evaluation of pramipexole in advanced Parkinson's disease: results of a double-blind, placebo-controlled, parallel-group study","volume":"49","author":"Lieberman","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2016.11.014_bib24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.pbb.2013.08.007","article-title":"The neural and genetic basis of executive function: attention, cognitive flexibility, and response inhibition","volume":"123","author":"Logue","year":"2014","journal-title":"Pharmcol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2016.11.014_bib25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1037\/a0019244","article-title":"Effects of pramipexole on impulsive choice in male wistar rats","volume":"18","author":"Madden","year":"2010","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2016.11.014_bib26","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1037\/a0016806","article-title":"Pathological gamblers discount probabilistic rewards less steeply than matched controls","volume":"17","author":"Madden","year":"2009","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2016.11.014_bib27","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1097\/00001756-200409150-00025","article-title":"Selective activation of the nucleus accumbens during risk-taking decision making","volume":"15","author":"Matthews","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2016.11.014_bib28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0922-4106(95)90013-6","article-title":"Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors","volume":"290","author":"Mierau","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.11.014_bib29","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1212\/WNL.52.5.938","article-title":"Restless legs syndrome improved by pramipexole: a double-blind randomized trial","volume":"52","author":"Montplaisir","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2016.11.014_bib30","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1093\/brain\/awv285","article-title":"Dynamic risk control by human nucleus accumbens","volume":"138","author":"Nachev","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2016.11.014_bib31","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/jcbfm.2011.201","article-title":"In\u00a0vivo mesolimbic D2\/3 receptor binding predicts posttherapeutic clinical responses in restless legs syndrome: a positron emission tomography study","volume":"32","author":"Oboshi","year":"2012","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neuropharm.2016.11.014_bib32","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2005"},{"key":"10.1016\/j.neuropharm.2016.11.014_bib33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1037\/a0024782","article-title":"Discounting of probabilistic rewards is associated with gambling abstinence in treatment-seeking pathological gamblers","volume":"121","author":"Petry","year":"2012","journal-title":"J.\u00a0Abnorm. Psychol."},{"key":"10.1016\/j.neuropharm.2016.11.014_bib34","first-page":"141","article-title":"Pharmacology of pramipexole, a dopamine D3-preferring agonist useful in treating Parkinson's disease","volume":"21","author":"Piercey","year":"1998","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2016.11.014_bib35","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00213-007-0957-y","article-title":"Single dose of a dopamine agonist impairs reinforcement learning in humans: behavioral evidence from a laboratory-based measure of reward responsiveness","volume":"196","author":"Pizzagalli","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2016.11.014_bib36","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.neuron.2006.06.024","article-title":"Neural differentiation of expected reward and risk in human subcortical structures","volume":"51","author":"Preuschoff","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2016.11.014_bib37","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1901\/jeab.1991.55-233","article-title":"Subjective probability and delay","volume":"55","author":"Rachlin","year":"1991","journal-title":"J.\u00a0Exp. Anal. Behav."},{"key":"10.1016\/j.neuropharm.2016.11.014_bib38","doi-asserted-by":"crossref","first-page":"e2479","DOI":"10.1371\/journal.pone.0002479","article-title":"Dopamine agonist increases risk taking but blunts reward-related brain activity","volume":"3","author":"Riba","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2016.11.014_bib39","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/npp.2011.325","article-title":"Pramipexole-induced increased probabilistic discounting: comparison between a rodent model of Parkinson's disease and controls","volume":"37","author":"Rokosik","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2016.11.014_bib40","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1468-1331.2009.02792.x","article-title":"Decision-making in Parkinson's disease patients with and without pathological gambling","volume":"17","author":"Rossi","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neuropharm.2016.11.014_bib41","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1126\/science.275.5306.1593","article-title":"A\u00a0neural substrate of prediction and reward","volume":"275","author":"Schultz","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2016.11.014_bib42","doi-asserted-by":"crossref","first-page":"17460","DOI":"10.1523\/JNEUROSCI.3772-11.2011","article-title":"Dopaminergic modulation of risky decision-making","volume":"31","author":"Simon","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.11.014_bib43","doi-asserted-by":"crossref","first-page":"8625","DOI":"10.1523\/JNEUROSCI.1020-11.2011","article-title":"Dissociable contributions by prefrontal D1 and D2 receptors to risk-based decision making","volume":"31","author":"St Onge","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.11.014_bib44","doi-asserted-by":"crossref","first-page":"16880","DOI":"10.1523\/JNEUROSCI.3807-12.2012","article-title":"Dynamic fluctuations in dopamine efflux in the prefrontal cortex and nucleus accumbens during risk-based decision making","volume":"32","author":"St Onge","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.11.014_bib45","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/npp.2008.121","article-title":"Dopaminergic modulation of risk-based decision making","volume":"34","author":"St Onge","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2016.11.014_bib46","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/npp.2012.240","article-title":"Receptor-specific modulation of risk-based decision making by nucleus accumbens dopamine","volume":"38","author":"Stopper","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2016.11.014_bib47","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1038\/npp.2009.124","article-title":"Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson's disease?","volume":"34","author":"van Eimeren","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2016.11.014_bib48","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archneurol.2010.65","article-title":"Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients","volume":"67","author":"Weintraub","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuropharm.2016.11.014_bib49","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0006-8993(00)02403-3","article-title":"Dopamine release from pharmacologically distinct storage pools in rat striatum following stimulation at frequency of neuronal bursting","volume":"870","author":"Yavich","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2016.11.014_bib50","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nature17400","article-title":"Nucleus accumbens D2R cells signal prior outcomes and control risky decision-making","volume":"531","author":"Zalocusky","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2016.11.014_bib51","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1038\/npp.2009.62","article-title":"Serotonergic and dopaminergic modulation of gambling behavior as assessed using a novel rat gambling task","volume":"34","author":"Zeeb","year":"2009","journal-title":"Neuropsychopharmacology"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390816305111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390816305111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T08:50:49Z","timestamp":1536223849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390816305111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":51,"alternative-id":["S0028390816305111"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.11.014","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pramipexole enhances disadvantageous decision-making: Lack of relation to changes in phasic dopamine release","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}